跳至主要内容
临床试验/NCT04245410
NCT04245410Unknown不适用

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Universidad de Extremadura1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Overall survival

研究概览

简要总结

Pancreatic metastases are a rare entity. In cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection.

Goals:

  • Define survival after resection of pancreatic cancer metastases renal in a wide range of our country.
  • Identify predictive survival factors

Methods:

Retrospective multicenter study in which cases of pancreatic resection due to renal cancer metastases.

详细描述

Introduction:

Pancreatic metastases are a rare entity and often synonymous with broader dissemination. However, in cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection. Most of the literature refers to isolated cases or short series, with the Johns Hopkins Hospital series being the largest in a single published center (1,2). In all of them, survival after resection is prolonged.

Recently, due to the results obtained with the tyrosine kinase inhibitor drugs, the value of resection of metastases of RCC origin has been questioned in an Italian multicenter study (3), although other studies consider that resection can improve the prognosis if It is associated with these drugs (4).

Justification:

The existing literature is limited to short series or mostly isolated cases. There are no clear prognostic factors that are limited in most cases to being merely descriptive studies.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with resecable pancreatic metastases from RCC

排除标准

  • Unresecable pancreatic metastases

结局指标

主要结局

Overall survival

时间窗: Up to 60 months

Overall survival (months) from surgical resection of pancreatic metastases

Disease free survival

时间窗: Up to 60 months

Disease free survival (months) from surgical resection of pancreatic metastases

次要结局

未报告次要终点

研究者

发起方
Universidad de Extremadura
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gerardo Blanco-Fernández

Head of Surgery, Clinical Professor

Universidad de Extremadura

研究点 (1)

Loading locations...

相似试验